The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism *

@article{Jackson2007TheEO,
  title={The effect of eflornithine 13.9\% cream on the bother and discomfort due to hirsutism *},
  author={Joseph Jackson and J. Jaime Caro and Graciela Caro and Frances B. Garfield and Ferdinand Huber and Wenjiong Zhou and Chen-Sheng Lin and Douglas Shander and Kathy Schrode},
  journal={International Journal of Dermatology},
  year={2007},
  volume={46}
}
Although unwanted facial hair often leads to anxiety and avoidance of social situations, evaluation of treatment outcomes in clinical trials has relied largely on measures external to the patient such as the extent of hair growth or an expert physician's assessment, neglecting to include patient reported outcomes (PRO). To assess the level of bother caused by a dermatological condition (hirsutism) and changes brought on by treatment, the instrument ESTEEM was developed by expanding the Bother… 
A method to improve the efficacy of topical eflornithine hydrochloride cream
TLDR
The integration of microneedle treatment into topical eflornithine therapy represents a potentially viable approach to increase eflORNithine's ability to inhibit hair growth.
No. 350-Hirsutism: Evaluation and Treatment.
Comprehensive clinical management of hirsutism
TLDR
A general overview of hirsutism treatment options is presented, which includes laser hair removal, electrolysis, depilatory creams, plucking and waxing.
Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines Drawn up by an Expert Working Group
TLDR
The expert working group reviews existing data and provides guidance on the use of eflornithine in combination with laser for resistant hirsutism.
Best Practice Options for Hair Removal in Patients with Unwanted Facial Hair Using Combination Therapy with Laser: Guidelines Drawn up by an Expert Working Group
TLDR
The expert working group reviews existing data and provides guidance on the use of eflornithine in combination with laser for resistant hirsutism.
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
TLDR
There was low quality evidence for the effect of two oral contraceptive pills (OCPs) and change in androgen levels were addressed in most comparisons, change in body mass index (BMI) and improvement of other clinical signs of hyperandrogenism in one-third of studies.
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments
TLDR
Lifestyle interventions reduced body mass index but did not show improvement in hirsutism, and although cosmetic measures are frequently used, no RCTs investigating cosmetic treatments were identified.
Hirsutism: An Evidence-Based Treatment Update
TLDR
The objective of this paper is to review and summarize current evidence evaluating the efficacy of various treatment modalities for hirsutism in premenopausal women.
...
...

References

SHOWING 1-10 OF 26 REFERENCES
Randomized, double‐blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair
TLDR
The results of two double-blind studies evaluating the efficacy and safety of eflornithine HCl 13.9% cream in women with unwanted facial hair are reported.
Quality of life of hirsute women.
TLDR
The results suggest that the complex management of hirsute women, in addition to pharmacological and/or cosmetic measures, may require specific psychotherapy.
Psychological morbidity in women referred for treatment of hirsutism.
[Acceptability, tolerance and quality of life impact of cyproterone acetate treatment in female hirsutism. Comparison of 2 protocols in combination with oral or transdermal estradiol].
TLDR
The hirsutism score has been found to be significantly correlated with anxious trouble but not with the global quality of life score, and measurement of treatment acceptance with a visual analogic scale has been finding globally very satisfactory by patients from the 2 groups.
Anxiety and Hirsutism
TLDR
To compare anxiety of 15 hirsute women and of 20 control subjects (student nurses) seen at the Soroka Medical Center, Israel, the first two hypotheses were confirmed but no correlation was found between extent of hirsutism and state or trait anxiety.
Interpreting treatment effects in randomised trials
TLDR
For some questionnaires, it is known that the smallest change in score that patients consider important is 0.5 per question, even if the mean difference between a treatment and a control is appreciably less than the smallest changes that is important, treatment may have an important impact on many patients.
Psychosomatic assessment of hirsute women.
TLDR
The majority of patients showed a good psychological adaptation to illness: they did not report significantly more anxiety, depression, and abnormal illness behavior than controls, but one-sixth of the patients suffered from a clinically meaningful affective disorder.
Interpreting the significance of changes in health-related quality-of-life scores.
TLDR
The significance of changes in QLQ-C30 scores can be interpreted in terms of small, moderate, or large changes in quality of life as reported by patients in the SSQ.
...
...